Orally disintegrating olanzapine for the treatment of a manic patient with esophageal stricture plus chronic pharyngitis

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 2, 2007, Pages 541-542

  Shen, Yu Chih ^a,b   Lee, Mei Ying ^a   Lin, Chaucer C H ^a,b   Chen, Chia Hsiang ^a,b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Chronic pharyngitis; Esophageal stricture; Olanzapine

Indexed keywords

OLANZAPINE; RISPERIDONE; VALPROIC ACID;

ADULT; ARTICLE; CASE REPORT; CHRONIC DISEASE; DRUG SOLUBILITY; ESOPHAGUS STRICTURE; FEMALE; HUMAN; MANIA; MENTAL PATIENT; PHARYNGITIS; RATING SCALE; SALIVA; SWALLOWING; SYMPTOMATOLOGY; TREATMENT OUTCOME; YOUNG MANIA RATING SCALE;

ADMINISTRATION, ORAL; ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; CHRONIC DISEASE; ESOPHAGEAL STENOSIS; FEMALE; HUMANS; PHARYNGITIS;

EID: 33846829610     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.09.003     Document Type: Article

References (10)

1. Castell D.O., and Donner M.W. Evaluation of dysphagia: a careful history is crucial. Dysphagia 2 (1987) 65-71
2. Citrome L. Re: treatment noncompliance with orally disintegrating olanzapine tablets. Can J Psychiatry 49 (2004) 413
3. Freudenreich O. Treatment noncompliance with orally disintegrating olanzapine tablets. Can J Psychiatry 48 (2003) 353-354
4. Kinon B.J., Hill A.L., Liu H., and Kollack-Walker S. Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia. Int J Neuropsychopharmacol 6 (2003) 97-102
5. Levine M.S., and Rubesin S.E. Diseases of the esophagus: diagnosis with esophagography. Radiology 237 (2005) 414-427
6. Marks R.D., and Richter J.E. Peptic strictures of the esophagus. Am J Gastroenterol 88 (1993) 1160-1173
7. Patterson D.J., Graham D.Y., Smith J.L., Schwartz J.T., Alpert E., Lanza F.L., et al. Natural history of benign esophageal stricture treated by dilatation. Gastroenterology 85 (1983) 346-350
8. Perkins D.O. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 63 (2002) 1121-1128
9. Reeves R.R., and Torres R.A. Orally disintegrating olanzapine for the treatment of psychotic and behavioral disturbances associated with dementia. South Med J 96 (2003) 699-701
10. Yatham L.N., Kennedy S.H., O'Donovan C., Parikh S., MacQueen G., McIntyre R., et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord 7 Suppl 3 (2005) 5-69